Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 2,000 shares, an increase of 566.7% from the March 31st total of 300 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 2,000 shares, the short-interest ratio is currently 1.0 days.
Aspen Pharmacare Trading Up 3.5 %
Shares of Aspen Pharmacare stock traded up $0.22 on Tuesday, hitting $6.59. 1,002 shares of the company's stock were exchanged, compared to its average volume of 1,384. The company has a current ratio of 1.81, a quick ratio of 1.07 and a debt-to-equity ratio of 0.30. Aspen Pharmacare has a 1 year low of $5.76 and a 1 year high of $13.69. The company has a 50-day simple moving average of $8.74 and a 200-day simple moving average of $9.21.
Aspen Pharmacare Company Profile
(
Get Free Report)
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Further Reading
Before you consider Aspen Pharmacare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.
While Aspen Pharmacare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.